Development of a drug screening platform based on engineered heart tissue.

Abstract

Tissue engineering may provide advanced in vitro models for drug testing and, in combination with recent induced pluripotent stem cell technology, disease modeling, but available techniques are unsuitable for higher throughput. Objective: Here, we present a new miniaturized and automated method based on engineered heart tissue (EHT).

Bibliographical data

Original languageGerman
Article number1
ISSN0009-7330
Publication statusPublished - 2010
pubmed 20448218